560 filings
Page 10 of 28
8-K
MBRX
Moleculin Biotech Inc
18 Oct 21
Moleculin Announces Interim Data in Phase 1b/2 Clinical Trial of Annamycin for the Treatment of Soft Tissue Sarcoma Lung Metastases
8:25am
8-K
MBRX
Moleculin Biotech Inc
13 Sep 21
Regulation FD Disclosure
8:01am
8-K
MBRX
Moleculin Biotech Inc
18 Aug 21
Regulation FD Disclosure
7:30am
8-K
MBRX
Moleculin Biotech Inc
12 Aug 21
Moleculin Reports Second Quarter 2021 Financial Results and Provides Programs Update
8:09am
10-Q
2021 Q2
MBRX
Moleculin Biotech Inc
Quarterly report
11 Aug 21
4:06pm
8-K
MBRX
Moleculin Biotech Inc
13 Jul 21
Regulation FD Disclosure
8:35am
4
MBRX
Moleculin Biotech Inc
12 Jul 21
Moleculin Biotech / WALTER V KLEMP ownership change
5:57pm
4
MBRX
Moleculin Biotech Inc
6 Jul 21
Moleculin Biotech / WALTER V KLEMP ownership change
7:30am
424B5
MBRX
Moleculin Biotech Inc
25 Jun 21
Prospectus supplement for primary offering
5:26pm
424B5
MBRX
Moleculin Biotech Inc
25 Jun 21
Prospectus supplement for primary offering
5:24pm
8-K
MBRX
Moleculin Biotech Inc
25 Jun 21
Entry into a Material Definitive Agreement
5:22pm
4
MBRX
Moleculin Biotech Inc
21 Jun 21
Moleculin Biotech / Jonathan P. Foster ownership change
4:21pm
4
MBRX
Moleculin Biotech Inc
21 Jun 21
Moleculin Biotech / DONALD H PICKER ownership change
4:20pm
4
Klemp Walter V
21 Jun 21
Moleculin Biotech / WALTER V KLEMP ownership change
4:20pm
8-K
MBRX
Moleculin Biotech Inc
21 Jun 21
Entry into a Material Definitive Agreement
4:17pm
8-K
MBRX
Moleculin Biotech Inc
21 Jun 21
Moleculin Announces First Subject Enrolled and Dosed in Phase 1b/2 Clinical Trial of Annamycin for the Treatment of Sarcoma Lung Metastases
8:35am
EFFECT
MBRX
Moleculin Biotech Inc
14 Jun 21
Notice of effectiveness
12:15am
4
MBRX
Moleculin Biotech Inc
9 Jun 21
Moleculin Biotech / MICHAEL D CANNON ownership change
4:26pm
4
MBRX
Moleculin Biotech Inc
9 Jun 21
Moleculin Biotech / Elizabeth Cermak ownership change
4:26pm
4
Climaco John M
9 Jun 21
Moleculin Biotech / John M Climaco ownership change
4:25pm